Cargando…
Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson’s disease
Peripheral biomarkers indicative of brain pathology are critically needed for early detection of Parkinson’s disease (PD). In this study, using NanoString and digital PCR technologies, we began by screening for alterations in genes associated with PD or atypical Parkinsonism in erythrocytes of PD pa...
Autores principales: | Liu, Xiaodan, Wang, Qilong, Yang, Ying, Stewart, Tessandra, Shi, Min, Soltys, David, Liu, Genliang, Thorland, Eric, Cilento, Eugene M., Hou, Yiran, Liu, Zongran, Feng, Tao, Zhang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941904/ https://www.ncbi.nlm.nih.gov/pubmed/33685516 http://dx.doi.org/10.1186/s40478-021-01133-6 |
Ejemplares similares
-
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
por: Tian, Chen, et al.
Publicado: (2019) -
Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson’s disease pathogenesis
por: Sheng, Lifu, et al.
Publicado: (2020) -
α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson’s disease
por: Liu, Zongran, et al.
Publicado: (2022) -
CHCHD2 and CHCHD10 regulate mitochondrial dynamics and integrated stress response
por: Ruan, Yu, et al.
Publicado: (2022) -
Erythrocytic alpha-synuclein as potential biomarker for the differentiation between essential tremor and Parkinson’s disease
por: Yu, Zhenwei, et al.
Publicado: (2023)